Antibiotic resistance is one of the greatest challenges of our time. This global health problem
originated from a paucity of truly effective antibiotic classes and an increased incidence of …

Engineered probiotic bacteria represent an innovative approach for treating and detecting a
wide range of diseases including those caused by infectious agents. Antimicrobial peptides …

Engineered bacteria are promising bioagents to synthesize antitumor drugs at tumor sites
with the advantages of avoiding drug leakage and degradation during delivery. Here, we …

Recombinantly produced biotherapeutics hold promise for improving the current standard of
care for snakebite envenoming over conventional serotherapy. Nanobodies have performed …

With the rapid spread of resistance among parasites and bacterial pathogens, antibiotic-
resistant infections have drawn much attention worldwide. Consequently, there is an urgent …

Biologics have become an important area of medical research generating therapeutics
essential for the treatment of many disease states. Biologics are defined as biologically …

Engineered living materials have the potential for wide-ranging applications such as
biosensing and treatment of diseases. Programmable cells provide the functional basis for …

The number of approved biopharmaceuticals, where product quality attributes remain of
major importance, is increasing steadily. Within the available variety of expression hosts, the …

Engineered yeast are an important production platform for the biosynthesis of high-value
compounds with medical applications. Recent years have witnessed several new …

Few monoclonal antibodies are currently approved for treating infectious diseases, but
multiple products are in development against a broad range of infectious diseases, including …